What Is the Price of NeoFipronis
NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, is a groundbreaking oral medication specifically formulated for the treatment of Feline Infectious Peritonitis (FIP). FIP is a severe, often fatal disease in cats characterized by symptoms such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. NeoFipronis has demonstrated remarkable efficacy in managing these symptoms and improving the quality of life for affected cats.
NeoFipronis was officially approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, marking it as the first authorized FIP-specific medication with a registered pharmaceutical license. Its approval underscores its safety, efficacy, and acceptance in veterinary medicine. The medication is easy to administer, safe, and non-invasive, with rapid absorption and a quick onset of action. It boasts minimal side effects and excellent tolerability, making it an ideal treatment option for feline patients.
The active component, GS-441524, is a nucleoside analogue that inhibits viral replication effectively. Extensive research and clinical trials have validated its potent antiviral capabilities, making NeoFipronis a sought-after therapy for FIP. The standard dosage is weight-based, with 15 mg per kilogram of body weight, roughly half a tablet. For cats exhibiting neurological or ocular symptoms, the dose can be increased to 30 mg/kg under veterinary supervision. The medication is recommended to be administered once daily, ideally on an empty stomach—either one hour before feeding or two hours after.
Length of treatment is critical—cats should undergo continuous therapy for no less than 12 weeks without interruptions to ensure optimal results. Monitoring during treatment is essential; pet owners should observe changes in appetite, temperature, and behavior. Regular blood tests to assess liver and kidney function are advised for safety. Although NeoFipronis is classified as an over-the-counter medication, veterinary guidance is strongly recommended for proper dosing and management, especially in complex cases such as nervous or ocular FIP.
The exact price of NeoFipronis may vary depending on several factors, including geographic location, dosage strength, and the vendor. Purchasing exclusively from official sources, such as the NeoFipronis official website, guarantees product authenticity and quality. Veterinary clinics and authorized pharmacies often provide the medication, sometimes with consultation services included.
In general, NeoFipronis is considered a premium FIP treatment, reflecting its advanced research, clinical success, and regulatory approval. Cost-wise, it is positioned at the higher end of feline antiviral medications due to its innovative formulation and efficacy. Prices can range broadly, typically between $150 and $300 per course of treatment, depending on the dosage and the length of therapy. Some veterinary practices may offer payment plans or discounts for longer courses or multiple vials.
Potential pet owners and veterinarian professionals should consider the long-term health benefits against the cost, as untreated FIP is inevitably fatal. Investing in NeoFipronis can significantly increase survival rates, reduce suffering, and improve outcomes. Always consult with a licensed veterinarian to determine the most appropriate treatment plan and confirm the best pricing options available locally.
Where to Buy NeoFipronis:
Always purchase from the official NeoFipronis website or authorized veterinary pharmacies to ensure quality and authenticity. Avoid third-party sources to prevent counterfeit products, which could compromise safety and treatment efficacy.
